Conduit Pharmaceuticals Inc (NASDAQ:CDT)’s traded shares stood at 6.42 million during the last session, with the company’s beta value hitting 2.29. At the close of
In the last trading session, 19.41 million Conduit Pharmaceuticals Inc (NASDAQ:CDT) shares changed hands as the company’s beta touched 2.25. With the company’s per share
Conduit Pharmaceuticals Inc (NASDAQ:CDT) has a beta value of 2.21 and has seen 8.02 million shares traded in the last trading session. The company, currently
Conduit Pharmaceuticals Inc (NASDAQ:CDT) has a beta value of 2.21 and has seen 11.22 million shares traded in the last trading session. The CDT stock
During the recent session, Conduit Pharmaceuticals Inc (NASDAQ:CDT)’s traded shares were 4.57 million, with the beta value of the company hitting 2.21. The company’s market
In the last trading session, 4.95 million shares of the Conduit Pharmaceuticals Inc (NASDAQ:CDT) were traded, and its beta was 2.20. Most recently the company’s
In the last trading session, 3.81 million shares of the Conduit Pharmaceuticals Inc (NASDAQ:CDT) were traded, and its beta was 2.19. Most recently the company’s
Conduit Pharmaceuticals Inc (NASDAQ:CDT)’s traded shares stood at 2.95 million during the last session, with the company’s beta value hitting 2.19. At the close of
Conduit Pharmaceuticals Inc (NASDAQ:CDT)’s traded shares stood at 5.43 million during the last session, with the company’s beta value hitting 2.20. At the close of
In the latest trading session, 4.17 million Conduit Pharmaceuticals Inc (NASDAQ:CDT) shares changed hands as the company’s beta touched 2.19. With the company’s most recent
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
